Search hospitals > California > San Diego
Naval Medical Center San Diego
Claim this profileSan Diego, California 92134
Global Leader in Breast Cancer
Global Leader in Lymphoma
Conducts research for Cancer
Conducts research for Leukemia
Conducts research for Tumors
210 reported clinical trials
13 medical researchers
Summary
Naval Medical Center San Diego is a medical facility located in San Diego, California. This center is recognized for care of Breast Cancer, Lymphoma, Cancer, Leukemia, Tumors and other specialties. Naval Medical Center San Diego is involved with conducting 210 clinical trials across 367 conditions. There are 13 research doctors associated with this hospital, such as Yoko T. Udaka, Michael E Hoffer, MD, Catherine Berjohn, MD, and Preston S. Gable.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
PR positive
2Lymphoma
Global LeaderStage IV
Stage II
Stage III
Top PIs
Yoko T. UdakaNaval Medical Center -San Diego7 years of reported clinical research
Studies Tumors
Studies Cancer
18 reported clinical trials
55 drugs studied
Michael E Hoffer, MDUniversity of Miami3 years of reported clinical research
Studies Traumatic Brain Injury
Studies Concussion
5 reported clinical trials
6 drugs studied
Catherine Berjohn, MDNaval Medical Center San Diego2 years of reported clinical research
Studies Diarrhea
Studies Flu
2 reported clinical trials
7 drugs studied
Preston S. GableNaval Medical Center -San Diego5 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
1 reported clinical trial
2 drugs studied
Clinical Trials running at Naval Medical Center San Diego
Non-Small Cell Lung Cancer
Traumatic Brain Injury
Lung Cancer
Osteosarcoma
Rhabdomyosarcoma
Germ Cell Tumors
Concussion
Ovarian Tumors
Brain Tumor
Non-Hodgkin's Lymphoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Naval Medical Center San Diego?
Naval Medical Center San Diego is a medical facility located in San Diego, California. This center is recognized for care of Breast Cancer, Lymphoma, Cancer, Leukemia, Tumors and other specialties. Naval Medical Center San Diego is involved with conducting 210 clinical trials across 367 conditions. There are 13 research doctors associated with this hospital, such as Yoko T. Udaka, Michael E Hoffer, MD, Catherine Berjohn, MD, and Preston S. Gable.